文献速递糖尿病

证据是否支持人群-wide 2型糖尿病筛查?否。

Does the evidence support population-wide screening for type 2 diabetes? No.
PubMed 文献 · Diabetologia · 2017-08-23

本文讨论大规模集中协调的2型糖尿病筛查能否降低心血管疾病和死亡等结局。基于少数相关试验的数据,整体上筛查项目直接相关的获益很少,部分原因是对照组机会性筛查水平高。当机会性筛查水平高时,集中协调的筛查项目尚无明确获益证据。

要点

  • 大规模集中协调的2型糖尿病筛查对心血管疾病和死亡等结局的直接获益证据有限。
  • 相关试验数据显示,筛查项目直接相关的获益很少,部分原因是对照组机会性筛查水平高。
  • 当机会性筛查水平高时,集中协调的筛查项目尚无明确获益证据。

核心结论

  • 当机会性筛查水平高时,集中协调的筛查项目尚无明确获益证据。

研究设计与样本

  • 本文为对同一领域少数相关试验数据的评述,引用两篇发表于Diabetologia的论文(DOI: 10.1007/s00125-017-4323-2 和 10.1007/s00125-017-4299-y)。

主要发现

  • 整体上,筛查项目直接相关的获益很少,部分原因是对照组机会性筛查水平高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Large-scale, centrally-coordinated screening for undiagnosed type 2 diabetes is an attractive option to reduce the mortality and morbidity resulting from inadequately controlled diabetes. However, there is limited research examining the direct consequences of such screening programmes on outcomes such as cardiovascular disease and death. Two papers published in this edition of Diabetologia (DOIs: 10.1007/s00125-017-4323-2 and 10.1007/s00125-017-4299-y ) examine data from one of the very few trials conducted in this area. Overall, there was little benefit that could be directly related to the screening programme. In part, this was due to the high levels of opportunistic screening in the control group. Thus, when there are high levels of opportunistic screening for type 2 diabetes, there remains no clear evidence of benefit of centrally-coordinated screening programmes that approach individuals outside usual healthcare settings.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Shaw JE. Does the evidence support population-wide screening for type 2 diabetes? No. Diabetologia. 2017. PMID: 28831520. doi:10.1007/s00125-017-4393-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。